Paaston ja laihdutuksen lisäksi: Tiede aineenvaihdunnan joustavuudesta ja miksi verensokerilla on enemmän merkitystä kuin kaloreilla

TL;DR:

• Metabolic flexibility — the ability to switch efficiently between glucose and fat as fuel sources — is emerging as a more useful framework for daily energy and long-term health than caloric restriction or macronutrient ratios alone.
• Chronically elevated blood glucose, even within the "normal" clinical range, drives insulin resistance, cognitive fog, energy crashes, and accelerated cellular ageing via glycation — making glucose stability a daily health priority, not just a diabetic concern.
• Nutritional support for blood glucose regulation — including ingredients like Berberine, Chromium picolinate, and Benfotiamine in Glucorine — represents a proactive metabolic health strategy well before clinical thresholds are reached.

The dominant nutritional narrative of the past five decades has been about calories — calories in, calories out, caloric restriction for weight management, caloric surplus for muscle gain. But a growing body of metabolic research suggests we have been asking a slightly wrong question. The more fundamental variable is not how many calories you consume, but how stable your blood glucose is — and how efficiently your body switches between fuel sources when glucose is unavailable. This metabolic flexibility determines daily energy, cognitive performance, sleep quality, hunger patterns, and the long-term risk trajectory of a remarkably wide range of chronic conditions.

Key Takeaways

Concept	Key Insight
Metabolic flexibility	The ability to use both glucose and fat as fuel — impaired in insulin-resistant individuals
Post-prandial spikes	Even "non-diabetic" glucose spikes above 140mg/dL trigger oxidative stress and glycation
Cognitive impact	Glucose crashes impair prefrontal cortex function — concentration, decision-making, mood regulation
Glycation	AGEs (advanced glycation end-products) from chronic hyperglycaemia accelerate tissue and skin ageing
Berberine AMPK activation	AMPK is the metabolic switch that improves both glucose uptake and fat oxidation simultaneously
Preventive window	Pre-diabetic and metabolically inflexible individuals have the most to gain from early nutritional intervention

What metabolic flexibility actually means

A metabolically flexible individual is one whose cells can oxidise glucose when it is abundant (after a carbohydrate meal) and seamlessly transition to oxidising fatty acids when glucose is scarce (after an overnight fast, during exercise, or between meals). This switching is regulated primarily by insulin — high insulin suppresses fat oxidation and promotes glucose uptake and storage; falling insulin promotes fat release from adipose tissue for energy. In metabolically healthy individuals, this transition is smooth, rapid, and energy-efficient.

In metabolically inflexible individuals — which describes a large and growing proportion of the adult population — the transition is impaired. Cells that have developed insulin resistance cannot efficiently upregulate glucose uptake in response to insulin, and the body's ability to shift to fat oxidation during fasting is also compromised. The result is a state of metabolic "middle ground" where neither fuel source is being utilised optimally — manifesting as persistent hunger, energy crashes, difficulty losing body fat, cognitive fog between meals, and poor sleep quality.

The glycaemic treadmill: why most people are stuck on glucose

The modern diet — high in refined carbohydrates, ultra-processed foods, and frequent eating occasions — creates a pattern of continuous glucose supply that the metabolic flexibility system was not evolved for. When glucose is continuously available, insulin remains chronically elevated. Chronically elevated insulin suppresses glucagon (the hormone that mobilises stored glucose) and inhibits hormone-sensitive lipase (the enzyme that releases fatty acids from adipose tissue for oxidation). The body becomes, essentially, locked in a glucose-dependent state.

The practical consequence is what many people recognise as "needing to eat every 2 to 3 hours to feel normal" — a pattern that is often misattributed to a "fast metabolism" but is more accurately described as metabolic inflexibility. The body has lost the capacity to comfortably bridge periods without glucose, because fat oxidation is chronically suppressed. Breaking this cycle requires strategies that lower average insulin levels and improve cellular insulin sensitivity — the combined goal of metabolic flexibility nutrition.

"Metabolic inflexibility is not a character flaw or a weakness of willpower. It is a physiological state — one that can be systematically addressed through diet, activity, and targeted nutritional support."

The cost of glucose spikes — beyond the obvious

Post-meal glucose excursions — the rise in blood sugar following a carbohydrate-containing meal — have consequences that extend well beyond weight management. Even in non-diabetic individuals, glucose spikes above approximately 140mg/dL trigger reactive oxygen species production in endothelial cells — the oxidative stress that initiates the vascular damage seen at more extreme levels in diabetes, but present at lower intensity in the "normal" population after high-glycaemic meals.

Simultaneously, glucose at elevated concentrations reacts non-enzymatically with proteins and lipids in a process called glycation — forming advanced glycation end-products (AGEs). AGEs accumulate in long-lived proteins like collagen (accelerating skin ageing and arterial stiffening), in the lens of the eye, and in neural tissue. Haemoglobin A1c — the standard clinical marker of blood glucose control — is itself a measure of glycated haemoglobin: the percentage of haemoglobin molecules that have undergone glucose attachment over the preceding 2 to 3 months. This test is ordered for diabetics, but the underlying process occurs on a spectrum throughout the normal range.

Insulin resistance: the spectrum that starts decades early

Type 2 diabetes is typically diagnosed when fasting blood glucose exceeds 126mg/dL or HbA1c exceeds 6.5%. Pre-diabetes is defined as fasting glucose of 100 to 125mg/dL or HbA1c of 5.7 to 6.4%. But insulin resistance — the cellular impairment in insulin signalling that underlies both — begins decades before these clinical thresholds are reached. Research using hyperinsulinaemic-euglycaemic clamp studies (the gold standard measure of insulin sensitivity) shows that significant insulin resistance exists in individuals with entirely normal glucose and HbA1c values.

The clinical thresholds for pre-diabetes and diabetes are defined around the point at which the pancreatic beta cells can no longer compensate for insulin resistance by producing more insulin. But the metabolic consequences of insulin resistance — impaired fat oxidation, elevated triglycerides, central adiposity, cognitive impairment, and systemic inflammation — are present well before blood glucose visibly rises. Intervening at the insulin resistance stage — before clinical pre-diabetes — is where the greatest preventive opportunity exists.

Continuous glucose monitoring: what we are learning

The democratisation of continuous glucose monitoring (CGM) technology — originally developed for diabetic management and now increasingly available to non-diabetic users — has generated valuable insights into glycaemic variability in healthy populations. Studies using CGM in healthy adults have found that many individuals show post-prandial glucose peaks above 140mg/dL in response to foods that would be considered healthy or moderate-glycaemic by conventional food labelling.

Individual glucose responses to identical foods vary dramatically — driven by gut microbiome composition, physical activity timing, sleep quality, stress levels, and individual insulin sensitivity variation. This personalisation of glycaemic response explains why population-level dietary guidelines are imprecise tools for individual metabolic health optimisation. It also suggests that many individuals who do not consider themselves at metabolic risk are experiencing more significant glucose excursions and insulin secretion peaks than they would expect — contributing incrementally to insulin resistance progression over years and decades.

Nutritional strategies for metabolic flexibility

The most effective dietary strategies for improving metabolic flexibility share a common principle: reducing chronic insulin exposure while preserving adequate protein and micronutrient intake. Time-restricted eating (compressing eating within a 6 to 10 hour window) reduces average daily insulin secretion and extends the overnight fasting period during which fat oxidation predominates. Lower carbohydrate dietary patterns reduce post-prandial insulin peaks. Prioritising protein at meals increases satiety and supports metabolic rate without significant insulin stimulation. Resistance exercise improves skeletal muscle insulin sensitivity by increasing GLUT-4 transporter expression independently of insulin.

Physical activity timing relative to meals also significantly modulates post-prandial glucose responses — a 10-minute walk after eating reduces post-meal glucose peaks by activating non-insulin-mediated glucose uptake in muscle. These behavioural strategies are the foundation of metabolic flexibility improvement, and nutritional support can meaningfully augment them at the biochemical level.

The role of blood sugar support supplements

Within a broader metabolic health strategy, evidence-based nutritional supplements can address specific biochemical mechanisms that diet and lifestyle cannot fully optimise. AMPK activators like berberine — the primary active compound in Glucorine — mimic the molecular effects of both exercise and caloric restriction on cellular energy sensing, improving insulin sensitivity and glucose uptake in muscle tissue while inhibiting hepatic glucose production. Chromium picolinate amplifies insulin receptor signalling through its chromodulin cofactor mechanism. Benfotiamine provides lipid-soluble thiamine at tissue levels sufficient to suppress the glycation pathway byproducts of elevated glucose. Ceylon cinnamon's MHCP fraction stimulates insulin receptor autophosphorylation, improving cellular insulin responsiveness at the receptor level.

These mechanisms are not substitutes for dietary and lifestyle intervention — they are amplifiers that act on the same physiological pathways, providing additive metabolic benefit when used alongside appropriate nutrition and activity patterns. The preventive window is wide: the metabolically inflexible individual who has not yet crossed clinical thresholds has the most to gain from multi-mechanism nutritional support, at a stage when the underlying insulin resistance is still highly modifiable.

Explore Glucorine with BioEssentials

Metabolic flexibility is not a specialist clinical concern reserved for diabetic individuals — it is a foundational dimension of daily health and performance that begins to matter well before any clinical diagnosis. Glucorine was formulated to support this preventive window with a multi-mechanism approach: berberine for AMPK activation, chromium picolinate for insulin amplification, benfotiamine for glycation pathway protection, and Ceylon cinnamon for insulin receptor support — providing comprehensive blood glucose stability support at the stage where it matters most.

Glucorine by BioEssentials — Multi-Mechanism Blood Sugar Support Formula

Frequently asked questions

What is the difference between blood sugar stability and low blood sugar?

Blood sugar stability refers to maintaining glucose levels within a moderate, consistent range — avoiding both the high spikes after carbohydrate-rich meals and the reactive low dips that follow insulin oversecretion in response to those spikes. Hypoglycaemia (clinically low blood sugar, typically below 70mg/dL) is a distinct medical condition, primarily relevant in diabetic individuals using insulin or sulfonylureas. Blood sugar support supplements like Glucorine aim for stability within the healthy range, not reduction to hypoglycaemic levels.

Is berberine the same as metformin for blood sugar?

Berberine and metformin share a key mechanism — both activate AMPK and inhibit complex I of the mitochondrial electron transport chain, resulting in similar cellular effects on glucose production and insulin sensitivity. Studies comparing the two compounds directly have found comparable effects on fasting glucose and HbA1c in type 2 diabetic populations over 3-month periods. However, berberine is a dietary supplement, not a pharmaceutical — it is not approved for medical use, has different pharmacokinetic properties, and should not be substituted for prescribed diabetes medication without medical supervision.

How does poor sleep affect blood glucose?

Sleep deprivation acutely impairs insulin sensitivity — studies show that a single night of inadequate sleep reduces insulin sensitivity by 20 to 25%, comparable to several months on a high-fat diet. The mechanism involves elevated cortisol and growth hormone during disrupted sleep, both of which antagonise insulin action. Chronic sleep deprivation also increases ghrelin (hunger hormone) and reduces leptin (satiety hormone), driving carbohydrate cravings that further challenge glucose stability. Sleep quality is therefore a significant metabolic health lever alongside diet and exercise.

What role does the gut microbiome play in glucose regulation?

The gut microbiome influences glucose metabolism through multiple pathways: short-chain fatty acid (SCFA) production from dietary fibre fermentation improves insulin sensitivity and reduces hepatic glucose output via GLP-1 secretion; specific bacterial species (notably Akkermansia muciniphila) are associated with improved glucose tolerance; and microbiome composition is a significant predictor of individual post-prandial glucose responses to identical foods — explaining a substantial portion of interpersonal glycaemic variability observed in CGM studies. Dietary fibre diversity and probiotic-rich foods are therefore metabolic health tools alongside more targeted nutritional supplements.

Can blood glucose stability support cognitive performance?

Yes — the brain is among the most glucose-dependent organs in the body, consuming approximately 20% of total glucose at rest despite comprising only 2% of body weight. Glucose fluctuations — both spikes and subsequent crashes — impair prefrontal cortex function, the brain region responsible for attention, working memory, decision-making, and emotional regulation. Post-prandial cognitive "fog" following high-glycaemic meals is a widely reported subjective experience with neuroimaging and performance testing correlates. Maintaining glucose stability throughout the day is therefore directly relevant to sustained cognitive performance, focus, and mood stability.

---

Recommended

• Multi-pathway liver support: the new standard — BioEssentials
• How to choose the right magnesium supplement: the 5-form buyer's guide — BioEssentials
• Sleep supplements: why the best go beyond melatonin — BioEssentials
• How to choose a hair supplement: 5 criteria beyond biotin — BioEssentials
• How to stack magnesium: 5 BioEssentials formulas explained — BioEssentials

Our research and formulas have been recognized by leading media outlets such as Marie Claire.

Scientific References

• Clinical evidence on Berberine efficacy and safety (PubMed)
• Mechanisms of action and bioavailability of Berberine (PMC)
• Evidence-based review: Berberine supplementation outcomes (PubMed)

These statements have not been evaluated by the Food and Drug Administration. BioEssentials products are food supplements intended to support general wellness and daily nutritional needs. They are not intended to diagnose, treat, cure, or prevent any disease. Always consult a healthcare professional before starting any new supplement if you are pregnant, breastfeeding, taking medication, or managing a health condition.